<!DOCTYPE html>
<html>
<head>
	<title>Website Title</title>
	<meta charset="UTF-8">
	<meta name="viewport" content="width=device-width, initial-scale=1.0">
	<link rel="stylesheet" type="text/css" href="css/bootstrap.min.css">
	<link rel="stylesheet" type="text/css" href="css/style2.css">
	<link rel="stylesheet" type="text/css" href="css/style.css">
	<!-- <link rel="icon" href="images/favicon.png"> -->
</head>
<body>
	<!-- <div class="loader-wrapper"><div class="loader"></div></div> -->
	<header class="site_header">
		<nav class="navbar navbar-expand-lg p-0 navbar-light align-items-start">
			<div class="container align-items-start">
				<a class="navbar-brand p-0 m-0" href="index.html">
					<img src="images/logo.png" alt="logo image">
				</a>
				<a href="javascript:void(0);" class="navbar_toggler d-lg-none">
					<div class="navbar_toggler_inner"></div>
				</a>
				<div class="collapse navbar-collapse" id="collapsibleNavbar">

					<ul class="navbar-nav ml-auto">
						<li class="nav-item logo d-lg-none">
							<a class="nav-link" href="index.html">
								<img src="images/logo.png" alt="logo image">
							</a>
						</li>
						<li class="nav-item">
							<a class="nav-link" href="#">PLGD <br>Overview</a>
						</li>
						<li class="nav-item">
							<a class="nav-link" href="#">Signs <br>Symptoms</a>
						</li>
						<li class="nav-item">
							<a class="nav-link" href="#">Affected Areas <br>of the Body</a>
						</li>
						<li class="nav-item">
							<a class="nav-link" href="#">Diagnosis <br>& Testing</a>
						</li>
						<li class="nav-item">
							<a class="nav-link" href="#">Treatments <br>& Care Management</a>
						</li>
						<li class="nav-item">
							<a class="nav-link" href="#">Patient <br>Resources</a>
						</li>
					</ul>
				</div>
			</div>
		</nav>
	</header>
	<section class="banner_section">
		<div class="container d-flex">
			<div class="banner_content w-100 d-flex flex-wrap flex-column justify-content-between">
				<h2>Parting the Clouds on <br>Plasminogen Deficiency Type 1 <span>(PLGD-1)</span></h2>

				<div class="row justify-content-center">
					<div class="col-12 mt-3 mt-sm-0 col-sm-6 col-md-4">
						<div class="banner_link text-center">
							<p class="text-white">Learn more about this <br>rare genetic disorder</p>
							<a href="#"><i class="fas fa-chevron-right"></i></a>
						</div>
					</div>
					<div class="col-12 mt-3 mt-sm-0 col-sm-6 col-md-4">
						<div class="banner_link text-center">
							<p class="text-white">Discover breakthroughs<br> in treatment options</p>
							<a href="#"><i class="fas fa-chevron-right"></i></a>
						</div>
					</div>
					<div class="col-12 mt-3 mt-md-0 col-sm-6 col-md-4">
						<div class="banner_link text-center">
							<p class="text-white">Find more PLGD-1 <br>resources</p>
							<a href="#"><i class="fas fa-chevron-right"></i></a>
						</div>
					</div>
				</div>
			</div>
		</div>
	</section>
	<section class="overview_section">
        <div class="container">
            <div class="border_heading">
                <h2>PLGD OVERVIEW</h2>
            </div>
            <div class="custom_note">
                <h4>What is plasminogen?</h4>
                <p>Plasminogen (PLG) is an important precursor protein that circulates in the bloodstream and is
                    converted into another protein called plasmin.<sup>1</sup></p>
                <p>Plasmin breaks down fibrin, the main protein in blood clots, and helps repair wounds so normal tissue
                    can grow back.<sup>1</sup></p>
                <p>Plasminogen is also involved in other functions of the body, allowing new blood vessels to form
                    (called “angiogenesis”) and aiding in the development of fertilized eggs during
                    pregnancy.<sup>2</sup></p>
            </div>
            <div class="custom_assets">
                <img src="images/overview_video.png" />
            </div>
            <div class="custom_note">
                <h4>What is plasminogen deficiency?</h4>
                <p>Plasminogen deficiency (PLGD) is an ultra-rare genetic condition that occurs when a person has a
                    mutation in both copies of the gene for plasminogen. People with PLGD may have <strong>abnormally
                        low PLG levels</strong> and <strong>low PLG activity</strong> (meaning the PLG that is present
                    doesn’t function properly), or normal levels of PLG but low levels of PLG activity.<sup>1,3,4</sup>
                </p>
                <div class="container">
                    <div class="row">
                        <div class="col-md-6">
                            <ul>
                                <li>PLGD is inherited in an autosomal recessive pattern, which means that affected
                                    individuals carry 2 copies of the PLG gene with mutations.
                                    <ul>
                                        <li>People who carry only 1 mutated PLG gene are carriers. Carriers usually do
                                            not show signs and symptoms of PLGD.</li>
                                    </ul>
                                </li>
                                <li>It is estimated that 1 to 2 people per million have PLGD.</li>
                                <li>To date, more females than males have been diagnosed.</li>
                            </ul>
                        </div>
                        <div class="col-md-6">
                            <ul>
                                <li>Abnormally low plasminogen levels combined with abnormally low plasminogen activity
                                    is called <strong>Plasminogen Deficiency Type 1, or hypoplasminogenemia
                                        (PLGD-1).</strong></li>
                                <li>A normal level of plasminogen with abnormally low activity is called
                                    <strong>Plasminogen Deficiency Type 2, or dysplasminogenemia (PLGD-2).</strong> It
                                    is usually asymptomatic (the person doesn’t show symptoms).</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
            <div class="custom_note">
                <h4>What are the symptoms of PLGD-1?</h4>
                <p><a href="#">Symptoms</a> of PLGD-1 manifest as “ligneous” growths (“ligneous” means “wood-like”) on
                    mucous membranes in various areas of the body.<sup>1,3-5</sup></p>
                <ul>
                    <li>These lesions form “pseudomembranes” or “false” membranes that replace the normal mucous
                        membranes that line body cavities or canals.</li>
                </ul>
                <div class="container">
                    <div class="row">
                        <div class="col-md-6">
                            <div class="custom_assets">
                                <figure>
                                    <img src="images/overview_symtoms01.png" alt="">
                                    <figcaption>
                                        <h6>Lesions on the eye</h6>
                                        <p>Image from Shapiro AD, Nakar C, Parker JM, et al. Blood 2018;131:1301-10.</p>
                                    </figcaption>
                                </figure>
                            </div>
                        </div>
                        <div class="col-md-6">
                            <div class="custom_assets">
                                <figure>
                                    <img src="images/overview_symtoms02.png" alt="">
                                    <figcaption>
                                        <h6>Lesions on the eye</h6>
                                        <p>Image from Shapiro AD, Nakar C, Parker JM, et al. Blood 2018;131:1301-10.</p>
                                    </figcaption>
                                </figure>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
        <div class="blue_gradient_bg">
            <div class="container">
                <h4>There are thought to be about 500 people suffering from PLGD-1 in the US<sup>5</sup></h4>
            </div>
        </div>
    </section>
    <section class="sign_and_symptom_section">
        <div class="container">
            <div class="border_heading">
                <h2>SIGNS & SYMPTOMS</h2>
            </div>
            <div class="custom_note">
                <h4>What are PLGD symptoms?</h4>
                <p>Symptomatic PLGD-1 is characterized by ligneous lesions, or abnormal growths (“ligneous” means
                    “wood-like”), that form on various mucous membranes of skin and organs throughout the
                    body.<sup>1,5</sup> </p>
                <p><a href="#">Common sites</a> where these lesions appear include the eyes, mouth, ears, nose,
                    respiratory tract, gastrointestinal tract, urinary tract, and female reproductive tract. Lesions can
                    vary in size, cause pain or discomfort, or affect how a person’s organs function.<sup>1,5</sup></p>
            </div>
            <div class="custom_qoute">
                <h5><span>"</span>My symptoms first appeared when I was 4 years old, with lesions inside my
                    eyelids.<span>"</span></h5>
                <p>—A patient with PLGD-1</p>
            </div>
            <div class="row">
                <div class="col-md-6">
                    <div class="custom_note">
                        <h4>When do symptoms appear?</h4>
                        <p>Symptoms can occur in infants as early as 3 days old but have also been reported for the
                            first time much later in life, in adults as old as 61 years of age. The average age of onset
                            is 9.54 months old.<sup>4</sup></p>
                        <p>Ligneous lesions often appear after minor injury or infection, but they may also appear
                            spontaneously. Removal of the lesions often leads to regrowth.<sup>5</sup></p>
                    </div>
                </div>
                <div class="col-md-6">
                    <div class="custom_note">
                        <h4>How long do symptoms last?</h4>
                        <p>Ligneous lesions can be persistent throughout a person’s life, or they can wax and
                            wane.<sup>4</sup> <a href="#">Depending on where they are located</a> they can cause
                            blindness, airway obstruction, or kidney failure. In some cases, complications can be
                            fatal.<sup>5</sup></p>
                    </div>
                </div>
            </div>
        </div>
    </section>
    <section class="affected_section">
		<div class="container">
			<div class="border_heading">
				<h2>AFFECTED AREAS OF THE BODY</h2>
			</div>
			<div class="custom_note">
				<h4>PLGD-1 is a systemic disease that can affect multiple organs throughout the body<sup>3</sup></h4>
			</div>
			<div class="custom_assets">
				<img src="images/affected_video.png" />
			</div>
			<div class="affected_list">
				<div class="row">
					<div class="col-md-6">
						<ul class="pr-md-5">
							<li>
								<div class="affected_list_img">
									<img src="images/icon_eyes.svg" />
								</div>
								<div class="affected_list_cont">
									<p><strong><span>81%</span> | Eyes:</strong> The most common symptom site of PLGD-1 is the lining of the eyelids, or conjunctiva.<sup>1,2,4</sup> <a href="#">More…</a></p>
								</div>
							</li>
							<li>
								<div class="affected_list_img">
									<img src="images/icon_mouth.svg" />
								</div>
								<div class="affected_list_cont">
									<p><strong><span>30%</span> | Mouth:</strong> The second most frequently affected site is the mouth or gums.<sup>3-5</sup> <a href="#">More…</a></p>
								</div>
							</li>
							<li>
								<div class="affected_list_img">
									<img src="images/icon_ears.svg" />
								</div>
								<div class="affected_list_cont">
									<p><strong><span>15%</span> | Ears:</strong> Lesions sometimes form on the mucous membranes of the middle ear and eardrum.<sup>3,4</sup> <a href="#">More…</a></p>
								</div>
							</li>
							<li>
								<div class="affected_list_img">
									<img src="images/icon_skin.svg" />
								</div>
								<div class="affected_list_cont">
									<p><strong><span>1%</span> | Skin:</strong> A skin condition called juvenile colloid milium can develop in children with PLGD-1.<sup>3,4</sup> <a href="#">More…</a></p>
								</div>
							</li>
						</ul>
					</div>
					<div class="col-md-6">
						<ul class="pl-md-5">
							<li>
								<div class="affected_list_img">
									<img src="images/icon_Brain.svg" />
								</div>
								<div class="affected_list_cont">
									<p><strong><span>12%</span> | Brain:</strong> In a few rare cases, children who have PLGD-1 are born with a buildup of fluid in the skull.<sup>1,4</sup> <a href="#">More…</a></p>
								</div>
							</li>
							<li>
								<div class="affected_list_img">
									<img src="images/icon_respiratory_tract.svg" />
								</div>
								<div class="affected_list_cont">
									<p><strong><span>20%</span> | Upper & Lower Respiratory Tract:</strong> When lesions develop in the windpipe (the trachea or bronchi), they can lead to serious complications.<sup>3-6</sup> <a href="#">More…</a></p>
								</div>
							</li>
							<li>
								<div class="affected_list_img">
									<img src="images/icon_female_genital_tract.svg" />
								</div>
								<div class="affected_list_cont">
									<p><strong><span>9%</span> | Female Reproductive Tract:</strong> Lesions in the female reproductive tract can cause painful menstrual cramps, pain during intercourse, and infertility.<sup>3-5</sup> <a href="#">More…</a></p>
								</div>
							</li>
							<li>
								<div class="affected_list_img">
									<img src="images/icon_kidney.svg" />
								</div>
								<div class="affected_list_cont">
									<p><strong><span>4%</span> | Kidneys:</strong> Lesions in the urinary tract can cause difficulty with processing fluids and urinating because of the blockages they create.<sup>4,5,7</sup> <a href="#">More…</a></p>
								</div>
							</li>
						</ul>
					</div>
					<div class="feature_img d-none d-md-block">
						<img src="images/affected_body_area.svg" />
					</div>
				</div>
			</div>
		</div>
		<div class="affected_btm_gradient"></div>
	</section>
	<section class="testing_section">
		<div class="container">
			<div class="border_heading">
				<h2>diagnosis and testing</h2>
			</div>
			<div class="custom_note">
				<h4>Diagnosing PLGD-1</h4>
				<p>PLGD-1 may be diagnosed at an early age, especially if the patient shows signs of <a href="#">ligneous conjunctivitis</a> (woody lesions on the inside of the eyelid). However, people with PLGD-1 who don’t show visible external lesions may not receive the proper diagnosis until they experience other physical problems much later in life.<sup>1,3,5</sup></p>
				<p>The condition is often misdiagnosed because medical specialists in one area of the body might not recognize PLGD lesions as being part of a <a href="#">systemic blood disorder</a> that can affect other organs.<sup>5</sup></p>
				<p>Both clinical and laboratory findings can be used to help identify if a person has congenital PLGD-1.<sup>7</sup></p>
			</div>
			<div class="custom_note">
				<h4>Clinical diagnosis</h4>
				<p>Healthcare providers may diagnose PLGD-1 after examining the patient and taking a detailed clinical history, including family history. When PLGD-1 is suspected, they will check for<sup>7</sup></p>
				<ul class="icon_list">
					<li>
						<img src="images/icon_eyes.png" alt="image">
						<p><span>External lesions,</span> especially on the eye, where 4 out of every 5 PLGD-1 cases show symptoms.</p>
					</li>
					<li>
						<img src="images/icon_PLGD.png" alt="image">
						<p><span>Signs of lesions elsewhere on the body.</span> Since multiple body systems can be affected, the ears, throat, respiratory tract, and female genital tract should also be examined to see if the lesions occur in other areas. Examining a child’s sun-exposed skin may show juvenile colloid milium, a rare skin condition associated with childhood PLGD-1.</p>
					</li>
					<li>
						<img src="images/icon_signs.png" alt="image">
						<p><span>A family history of PLGD.</span> As PLGD-1 is an inherited condition, a family history can support the diagnosis, especially when other affected siblings or family members have been tested with laboratory tests.</p>
					</li>
				</ul>
			</div>
			<div class="custom_note mb-0">
				<h4>Laboratory diagnosis</h4>
				<p>To confirm or rule out a suspicion of PLGD, a variety of tests are available that can also help determine the severity of the condition. These include<sup>8</sup>:</p>
				<div class="row justify-content-center">
					<div class="col-12 mt-3 mt-sm-0 col-sm-6 col-md-4">
						<div class="testing_box">
							<img src="images/test_image.png" alt="test image" class="mx-auto d-block">
							<p class="text-center m-0"><span>Laboratory tests,</span> called assays, for plasminogen (PLG). <a href="#">More…</a></p>
						</div>
					</div>
					<div class="col-12 mt-3 mt-sm-0 col-sm-6 col-md-4">
						<div class="testing_box">
							<img src="images/test_image_2.png" alt="test image" class="mx-auto d-block">
							<p class="text-center m-0"><span>Lesion biopsy,</span> where a surgically removed lesion is examined under a microscope <a href="#">More…</a></p>
						</div>
					</div>
					<div class="col-12 mt-3 mt-sm-0 mt-md-0 col-sm-6 col-md-4">
						<div class="testing_box">
							<img src="images/test_image_3.png" alt="test image" class="mx-auto d-block">
							<p class="text-center m-0"><span>Genetic testing</span> for mutations in the gene coding for plasminogen* <a href="#">More…</a></p>
						</div>
					</div>
				</div>
				<p class="testing_text mb-0">*Commercial genetic testing at-home kits do not test for PLGD-1. Ask your healthcare provider for a referral to a board-certified geneticist.</p>
			</div>
		</div>
	</section>
	<section class="treatment_section">
		<div class="container">
			<div class="border_heading">
				<h2>TREATMENTS & CARE MANAGEMENT</h2>
			</div>
			<div class="custom_note">
				<h4>PLGD-1 prognos</h4>
				<p>is Because PLGD-1 is so rare, there is much that is unknown about the condition, including how to
					predict a patient’s illness manifestations over the course of their life. There is no available cure
				for PLGD-1, but new treatment options for symptom relief have been developed.5</p>
			</div>
			<div class="custom_note">
				<h4>PLGD-1 treatments</h4>
				<p>The treatment goal for patients with PLGD-1 is to restore functional plasminogen levels.</p>
			</div>
			<div class="row">
				<div class="col-md-6">
					<div class="custom_note">
						<ul class="with_blue_marker">
							<li><strong>Fresh frozen plasma</strong>—administered topically or
								intravenously.<sup>5</sup>
							</li>
							<li><strong>Plasminogen concentrate</strong>—sourced from human plasma and concentrated to
								therapeutic plasminogen levels. Administered intravenously.<sup>12</sup>
							</li>
						</ul>
					</div>
				</div>
				<div class="col-md-6">
					<div class="custom_note">
						<ul class="with_blue_marker">
							<li><strong>Surgical removal</strong>—the lesion is surgically removed.<sup>5</sup>
							</li>
							<li>Other treatments that have been tried (not FDA approved) include high-dose
								corticosteroids, immunosuppressants, proteolytic enzymes (proteins that break down other
								proteins) and blood thinners.<sup>5</sup>
							</li>
						</ul>
					</div>
				</div>
			</div>
			<div class="custom_note">
				<p>It is always important to talk to your healthcare professional to determine what is best for you.</p>
			</div>
			<div class="custom_note">
				<h4>Care management</h4>
				<p>Patients may initially seek care from various specialists depending on their case, how old they are,
					and where their lesions appear—for example, from family doctors, pediatricians, ophthalmologists, or
					dentists. Because PLGD-1 is a <a href="#">systemic condition</a> with <a
					href="symptoms">symptoms</a> that affect <a href="#">various regions</a> of the body,
					coordinated care may be needed from healthcare providers in multiple disciplines<sup>3,5,13</sup>:
				</p>
				<div class="row">
					<div class="col-md-8">
						<ul class="with_blue_marker">
							<li>
								<strong>Pediatric or adult hematologists</strong> (physicians who care for patients with
								disorders of the blood)
								<ul>
									<li>PLGD-1 is fundamentally a <a href="#">blood or coagulation disorder</a>, even though
									symptoms appear on specific parts of the body </li>
									<li>Hemophilia treatment centers (HTCs) provide comprehensive care for people with inherited
									blood disorders like PLGD-1</li>
								</ul>
							</li>
							<li><strong>Ophthalmologists</strong> (physicians who care for eyes and the visual system) </li>
							<li><strong> or ear, nose, and throat (ENT) physicians</strong></li>
							<li><strong>Oral surgeons</strong></li>
							<li><strong>Pulmonologists</strong> (physicians who care for patients with lung or respiratory tract
							diseases) </li>
							<li><strong>Geneticists</strong> (physicians who test and counsel patients with genetic diseases)
								<ul>
									<li>Commercial at-home genetic testing kits do not test for PLGD-1. If you or a family
										member suspect PLGD-1, it is important to ask your primary healthcare provider for a
									referral to a board-certified geneticist.</li>
								</ul>
							</li>
						</ul>
					</div>
					<div class="col-md-4">
						<img src="images/care_management_img.png" class="m-auto" />
					</div>
				</div>
			</div>
			<div class="custom_qoute">
				<h5><span>"</span>I’ve been to so many specialists over the years for my lesions, but my hematologist
					put all my symptoms together.<span>"</span>
				</h5>
				<p>—A patient with PLGD-1</p>
			</div>
		</div>
	</section>
	<section class="patient_resource_section">
		<div class="container">
			<div class="border_heading">
				<h2>PATIENT RESOURCES</h2>
			</div>
			<div class="custom_note">
				<h4>You are not alone</h4>
			</div>
			<div class="row">
				<div class="col-12">
					<div class="custom_assets">
						<figure>
							<img src="images/patient_video01.png" alt="">
							<figcaption>
								<p>See one patient’s journey from symptom development to diagnosis.</p>
							</figcaption>
						</figure>
					</div>
				</div>
				<div class="col-md-6">
					<div class="custom_assets">
						<figure>
							<img src="images/patient_video02.png" alt="">
							<figcaption>
								<p>Heather’s patient testimonial</p>
							</figcaption>
						</figure>
					</div>
				</div>
				<div class="col-md-6">
					<div class="custom_assets">
						<figure>
							<img src="images/patient_video03.png" alt="">
							<figcaption>
								<p>Amy’s caregiver testimonial</p>
							</figcaption>
						</figure>
					</div>
				</div>
			</div>
			<div class="custom_qoute">
				<h5><span>"</span>The PLGD-1 community is small, but we’re tight-knit!<span>"</span></h5>
				<p>—A patient with PLGD-1</p>
			</div>
			<div class="custom_note">
				<h4>Helpful links</h4>
				<p>If you suspect you or a loved one is suffering with PLGD-1, you are not alone. These organizations
					promote PLGD-1 awareness, engage in pioneering research, and connect patients to resources to help
				manage their disease.</p>
			</div>
			<div class="row">
				<div class="col-md-6">
					<div class="custom_assets">
						<img src="images/brand_logo01.png" alt="">
						<figcaption class="text-center">
							<p>Find your <a href="#">PLGD-1 community.</a></p>
						</figcaption>
					</div>
				</div>
				<div class="col-md-6">
					<div class="custom_assets">
						<img src="images/brand_logo02.png" alt="">
						<figcaption class="text-center">
							<p><a href="#">Read more</a> about cutting-edge PLGD-1 research and clinical studies.</p>
						</figcaption>
					</div>
				</div>
				<div class="col-md-6">
					<div class="custom_assets">
						<img src="images/brand_logo03.png" alt="">
						<figcaption class="text-center">
							<p><a href="#">Read more</a> about PLGD-1 and learn about resources for patients and
							families in the rare disease community.</p>
						</figcaption>
					</div>
				</div>
				<div class="col-md-6">
					<div class="custom_assets">
						<img src="images/brand_logo04.png" alt="">
						<figcaption class="text-center">
							<p>Promoting international research into <a href="#">rare coagulation disorders like
							PLGD-1.</a></p>
						</figcaption>
					</div>
				</div>
			</div>
			<div class="description">
				<p>
					<strong>1.</strong> Congenital plasminogen deficiency. MedlinePlus website. https://medlineplus.gov/genetics/condition/congenital-plasminogen-deficiency/#resources. Updated: November 26, 2021. Accessed: May 2, 2022.
					<strong>2.</strong> Castellino FJ, Ploplis VA. Structure and function of the plasminogen/plasmin system. <em>Thromb Haemost</em>. 2005;93(04):647-54.
					<strong>3.</strong> Schuster V, Seregard S. Ligneous conjunctivitis. <em>Surv Ophthalmol</em>. 2003;48(4):369-388.
					<strong>4.</strong> Schuster V, Hügle B, Tefs K. Plasminogen deficiency. <em>J Thromb Haemost</em>. 2007;5(12):2315-2322.
					<strong>5.</strong> Shapiro AD, Menegatti M, Palla R, et al. An international registry of patients with plasminogen deficiency (HISTORY). <em>Haematologica</em>. 2020;105(3):554-561.
					<strong>6.</strong> Tefs K, Gueorguieva M, Klammt J, et al. Molecular and clinical spectrum of type I plasminogen deficiency: a series of 50 patients. <em>Blood</em>. 2006;108(9):3021-6.
					<strong>7.</strong> Congenital plasminogen deficiency. NORD website. https://rarediseases.org/rare-diseases/congenital-plasminogen-deficiency/. Accessed: May 2, 2022.
					<strong>8.</strong> Mehta R, Shapiro AD. Plasminogen deficiency. <em>Haemophilia</em>. 2008;14:1261-8.
					<strong>9.</strong> Caputo R, Pucci N, Mori F, et al. Long-term efficacy of surgical removal of pseudomembranes in a child with ligneous conjunctivitis treated with plasminogen eyedrops. <em>Thromb Haemost</em>. 2008;100:1196-8. doi:10.1160/ TH08-04-0233.
					<strong>10.</strong> National Organization for Rare Disorders (NORD) website. https://rarediseases.org/rare-diseases/congenital-plasminogen-deficiency/. Accessed May 2, 2022.
					<strong>11.</strong> Genetic counseling. National Human Genome Research Institute website. https://www.genome.gov/genetics-glossary/Genetic-Counseling. Accessed: May 2, 2022.
					<strong>12.</strong> Ryplazim. Prescribing Information. Kedrion Biopharma Inc; 2021. 13. Plasminogen deficiency. Indiana Hemophilia & Thrombosis Center website. https://www.ihtc.org/plasminogen-deficiency. Accessed May 2, 2022.
				</p>
			</div>
		</div>
	</section>
	<footer class="site_footer">
		<div class="container">
			<div class="row align-items-center">
				<div class="col-sm-6">
					<p class="mb-0 text-white">Kedrion Biopharma Inc., All rights reserved.</p>
					<p class="mb-0 text-white">May 2022 RY-0021-00-2022</p>
					<p class="mb-0 text-white">INTENDED FOR US AUDIENCES ONLY</p>
				</div>
				<div class="col-sm-6">
					<div class="d-table ml-sm-auto mt-4 mt-sm-0">
						<img src="images/kedrion_logo.png">
					</div>
				</div>
			</div>
		</div>
	</footer>
	<script src="js/jquery.min.js"></script>
	<script src="js/fonts-awesome-5.js"></script>
	<script src="js/bootstrap.bundle.min.js"></script>
	<script src="js/popper.min.js"></script>
	<script src="js/custom.js"></script>
</body>
</html>